Table 3. Characteristics of patients in the DUES(+) and DUES(-) groups.
| DUES(+) group | DUES(-) group | P valueb) | ||
|---|---|---|---|---|
| (18 patients, 18 eyes) | (56 patients, 56 eyes) | |||
| Gender (n) | Male | 11 | 35 | 0.9158 |
| Female | 7 | 21 | ||
| Age (years) | 70.0 ± 13.1 | 64.9 ± 12.9 | 0.1491 | |
| Preop IOP (mmHg) | 18.4 ± 4.6 | 21.1 ± 8.0 | 0.1640 | |
| Preop MD (dB) | −19.4 ± 7.3 | −17.8 ± 7.6 | 0.4355 | |
| No. of anti-glaucoma agents used concomitantlya) | 2.7 ± 0.6 | 2.5 ± 0.6 | 0.2694 | |
| β blocker n (%) | 15(83.3%) | 49(87.5%) | 0.6528 | |
| Carbonic anhydrase inhibitor n (%) | 17(94.4%) | 51(91.1%) | 0.6483 | |
| Brimonidine n (%) | 12(66.7%) | 20(35.7%) | 0.0211 | |
Data are expressed as mean ± standard deviation or number of patients (%).
a)Combination formulation is counted as one agent.
b)analyzed by unpaired t-test. Preop = preoperative; IOP = intraocular pressure; MD = mean deviation